MedMen Enterprises (MedMen Enterprises) FCF Margin % : -47.64% (As of Mar. 2023)

View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. MedMen Enterprises's Free Cash Flow for the three months ended in Mar. 2023 was $-13.0 Mil. MedMen Enterprises's Revenue for the three months ended in Mar. 2023 was $27.2 Mil. Therefore, MedMen Enterprises's FCF Margin % for the quarter that ended in Mar. 2023 was -47.64%.

As of today, MedMen Enterprises's current FCF Yield % is -3,178,300.00%.

The historical rank and industry rank for MedMen Enterprises's FCF Margin % or its related term are showing as below:

MMNFF' s FCF Margin % Range Over the Past 10 Years
Min: -26.46 Med: 0 Max: 0
Current: -26.46

MMNFF's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: -0.2 vs MMNFF: -26.46

MedMen Enterprises FCF Margin % Historical Data

The historical data trend for MedMen Enterprises's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises FCF Margin % Chart

MedMen Enterprises Annual Data

Trend

Oct13

Oct14

Oct15

Oct16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

FCF Margin %

Get a 7-Day Free Trial

-322.92

-302.69

-110.31

-47.85

-51.26

MedMen Enterprises Quarterly Data
	Apr18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
FCF Margin %	Get a 7-Day Free Trial															-37.88	-13.43	-32.07	-15.92	-47.64

Competitive Comparison of MedMen Enterprises's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedMen Enterprises's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's FCF Margin % distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's FCF Margin % falls into.

MedMen Enterprises FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

MedMen Enterprises's FCF Margin for the fiscal year that ended in Jun. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2022 )	/	Revenue (A: Jun. 2022 )
	=	-72.185	/	140.812
	=	-51.26 %

MedMen Enterprises's FCF Margin for the quarter that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2023 )	/	Revenue (Q: Mar. 2023 )
	=	-12.97	/	27.225
	=	-47.64 %

MedMen Enterprises FCF Margin % Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMen Enterprises (MedMen Enterprises) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

0JS:Germany MMEN:Canada

Address

10115 Jefferson Boulevard, Culver City, CA, USA, 90232

Website

https://www.medmen.com

MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.